Base4 Biotechnology

About:

Harnessing atomic-scale biochemistry, quantum physics, and AI for RNA-targeted drug discovery and development.

Top Investors: Hopen Life Science Ventures, Orchard Venture Partners

Description:

Base4 is redefining RNA-targeted therapeutics through novel small molecule modulation to go after previously untreatable diseases. Powered by our revolutionary structure-based discovery platform, we are solving complicated diseases in several disease areas including neurology, oncology, and rare diseases.

Total Funding Amount:

$3.89M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2009-01-01

Contact Email:

bd(AT)base4.bio

Founders:

Josh Fairbank

Number of Employees:

11-50

Last Funding Date:

2010-01-01

IPO Status:

Private

Industries: